Annual report pursuant to Section 13 and 15(d)

Inventories (Tables)

v3.21.2
Inventories (Tables)
12 Months Ended
May 31, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current

​

​

​

​

​

​

​

​

​

    

May 31,

​

​

2021

​

2020

Raw materials

​

$

28,085

​

$

19,147

Work-in-progress

​

 

65,394

​

 

—

Total

​

$

93,479

​

$

19,147

Schedule of remaining shelf life of inventory

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Expiration period ending May 31,

​

Remaining shelf-life

​

​

Raw materials

​

​

Work-in-progress bulk drug product

​

​

Work-in-progress finished drug product in vials

​

​

Total inventories

2022

​

0 to 12 months

​

$

2,684

​

$

-

​

$

-

​

$

2,684

2023

​

12 or 24 months

​

​

19,750

​

​

-

​

​

-

​

​

19,750

2024

​

24 to 36 months

​

​

682

​

​

-

​

​

-

​

​

682

2025

​

36 to 48 months

​

​

1,792

​

​

-

​

​

29,633

​

​

31,425

2026

​

48 to 60 months

​

​

732

​

​

-

​

​

-

​

​

732

Thereafter

​

60 or more months

​

​

3,140

​

​

35,761

​

​

-

​

​

38,901

Total inventories

​

​

​

​

28,780

​

​

35,761

​

​

29,633

​

​

94,174

Inventories reserved

​

​

​

​

(695)

​

​

-

​

​

-

​

​

(695)

Total inventories, net

​

​

​

$

28,085

​

$

35,761

​

$

29,633

​

$

93,479